This is a preview of subscription content,
to check access.Reference
Prencipe N, et al. Biliary adverse events in acromegaly during somatostatin receptor ligands: predictors of onset and response to ursodeoxycholic acid treatment. Pituitary 24: 242-251, No. 2, Apr 2021. Available from: URL: http://doi.org/10.1007/s11102-020-01102-7
Rights and permissions
About this article
Cite this article
Octreotide/pasireotide. Reactions Weekly 1887, 540 (2022). https://doi.org/10.1007/s40278-022-08204-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-022-08204-2